COVID-19 in older people with cognitive impairment in Latin America

for the Latin America and the Caribbean Consortium on Dementia (LAC-CD)

doi:10.1016/S1474-4422(20)30270-2

COVID-19 in older people with cognitive impairment in Latin America

for the Latin America and the Caribbean Consortium on Dementia (LAC-CD)

Escuela de Psicología

Producción científica: Contribución a una revista › Carta › revisión exhaustiva

22 Citas (Scopus)

Idioma original	Inglés
Páginas (desde-hasta)	719-721
Número de páginas	3
Publicación	The Lancet Neurology
Volumen	19
N.º	9
DOI	https://doi.org/10.1016/S1474-4422(20)30270-2
Estado	Publicada - sep. 2020

Acceder al documento

10.1016/S1474-4422(20)30270-2

Citar esto

@article{16c9ddf70e1541df8f1f8d8180dba6b0,

title = "COVID-19 in older people with cognitive impairment in Latin America",

author = "{for the Latin America and the Caribbean Consortium on Dementia (LAC-CD)} and Agustin Ibanez and Kosik, {Kenneth S.}",

note = "Funding Information: We thank Alzheimer's Association, the Global Brain Health Institute, the Tau Consortium, the National Institutes of Health and National Institute on Aging, Inter-American Development Bank, and the Multi-Partner Consortium to Expand Dementia Research in Latin America (ReDLat). We also thank Margherita Melloni for her insightful revision of an early version of this manuscript. The contents of this publication are solely the responsibility of the authors and do not represent the official views of these institutions. AI is partly supported by grants from CONICET, CONICYT and FONDECYT Regular (1170010 and 1171200), FONCYT-PICT (2017-1818 and 2017-1820), ANID and FONDAP (15150012), the INECO Foundation, the Inter-American Development Bank, the Global Brain Health Institute (ALZ UK-20-639295), National Institutes of Health and National Institute on Aging (R01 AG057234), and the Multi-Partner Consortium to Expand Dementia Research in Latin America (ReDLat). KSK declares no competing interests. This Comment was written on behalf of the Latin America and the Caribbean Consortium on Dementia ( LAC-CD ); see the appendix (pp 1–2) for the full Consortium author list. ",

year = "2020",

month = sep,

doi = "10.1016/S1474-4422(20)30270-2",

language = "English",

volume = "19",

pages = "719--721",

journal = "The Lancet Neurology",

issn = "1474-4422",

publisher = "Elsevier Ltd.",

number = "9",

}

TY - JOUR

T1 - COVID-19 in older people with cognitive impairment in Latin America

AU - for the Latin America and the Caribbean Consortium on Dementia (LAC-CD)

AU - Ibanez, Agustin

AU - Kosik, Kenneth S.

N1 - Funding Information: We thank Alzheimer's Association, the Global Brain Health Institute, the Tau Consortium, the National Institutes of Health and National Institute on Aging, Inter-American Development Bank, and the Multi-Partner Consortium to Expand Dementia Research in Latin America (ReDLat). We also thank Margherita Melloni for her insightful revision of an early version of this manuscript. The contents of this publication are solely the responsibility of the authors and do not represent the official views of these institutions. AI is partly supported by grants from CONICET, CONICYT and FONDECYT Regular (1170010 and 1171200), FONCYT-PICT (2017-1818 and 2017-1820), ANID and FONDAP (15150012), the INECO Foundation, the Inter-American Development Bank, the Global Brain Health Institute (ALZ UK-20-639295), National Institutes of Health and National Institute on Aging (R01 AG057234), and the Multi-Partner Consortium to Expand Dementia Research in Latin America (ReDLat). KSK declares no competing interests. This Comment was written on behalf of the Latin America and the Caribbean Consortium on Dementia ( LAC-CD ); see the appendix (pp 1–2) for the full Consortium author list.

PY - 2020/9

Y1 - 2020/9

UR - http://www.scopus.com/inward/record.url?scp=85089535024&partnerID=8YFLogxK

U2 - 10.1016/S1474-4422(20)30270-2

DO - 10.1016/S1474-4422(20)30270-2

M3 - Letter

C2 - 32822627

AN - SCOPUS:85089535024

SN - 1474-4422

VL - 19

SP - 719

EP - 721

JO - The Lancet Neurology

JF - The Lancet Neurology

IS - 9

ER -